Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis. - Wikidata - wikimedia - TriplyDB

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.

http://www.wikidata.org/entity/Q44896647

about

Significance of Ovarian Function Suppression in Endocrine Therapy for Breast Cancer in Pre-Menopausal Women The Right Treatment for the Right Patient – Personalised Treatment of Breast Cancer Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.The impact of comorbidity on cancer survival: a review Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.Treatment and outcomes in diabetic breast cancer patients.Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.Understanding tamoxifen adherence in women with breast cancer: A qualitative study.Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer?Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider.The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom.Impact of disease management programs on women with breast cancer in Germany.Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis.Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.First-line treatment disruption among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study.Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.Optimal management of luminal breast cancer: how much endocrine therapy is long enough?

P2860

Q26745464-5AEA6E31-88F9-4BFD-BE37-39CAA9FC245B Q26800260-3024D199-275A-4F6F-ADE3-865C9062E39F Q35207952-C7F5266E-024B-4B25-B950-E5418E5568D0 Q37182285-BF9E4AA7-97AB-46C2-B8A4-E708EF510405 Q37185856-37797281-8992-4C44-A00B-4C64B2632BD6 Q37288186-D3A1A043-26F2-435F-9AFC-915F52B485C4 Q37669380-94C02797-A927-4BBD-AD9F-1573EBABFE97 Q38180008-99E7EFC9-4EE5-4FB5-AF9B-C62FE5310C00 Q38225433-9930F232-739F-4B55-AE71-71431D703887 Q38399176-40CC93F8-6457-48F1-995E-62CF2DCC3A26 Q38756269-6C3A0AC3-55E5-4B3B-BD02-A3C2AFD9DAEC Q39204185-79B5A847-2B5D-41F3-862B-1EFB07830E54 Q40188993-14EED214-DF71-4D16-AF61-9F06BD8169EB Q41492143-0DE6A5FA-5AC5-497C-A137-B04D0F0360A0 Q43604194-210D4249-5B73-4B4A-AFF9-D98586BDBAC8 Q45986611-A088AFAB-2C34-4F28-B6B0-C335F00F6A83 Q47192770-52274559-C3F6-4162-817B-687710752032 Q47656859-E37F7046-D5BB-42C0-B1DC-03BBAF0C1F29 Q47830773-D7B7E969-A690-4F8D-8B88-4D391AE3336F Q52632715-466008A3-6AF9-407C-8B90-39A3870755FB Q55424072-DDDDE83C-CFA2-442E-8E38-C0E0C5427C69

P2860

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.

http://www.wikidata.org/entity/Q44896647

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Persistence in patients with b ...... trospective database analysis.

@en

Persistence in patients with b ...... trospective database analysis.

@nl

type

label

Persistence in patients with b ...... trospective database analysis.

@en

Persistence in patients with b ...... trospective database analysis.

@nl

prefLabel

Persistence in patients with b ...... trospective database analysis.

@en

Persistence in patients with b ...... trospective database analysis.

@nl

P1433

Q44896647-F337465D-180E-4F48-83E8-EF90D2E8241B

P1476

Q44896647-5B2FADF8-723C-4A3E-AFBF-4FBFEA3AE672

P2093

Q44896647-35655303-40A2-48F3-8AB0-E30B20230A44

Q44896647-6AF7E4F3-9CD2-4C1E-8E14-DB2FCBFAF30C

Q44896647-B41F365F-2AFF-4212-8FBF-B990F94848A9

Q44896647-D01D705A-9DDE-41D0-8277-CD1CA500558B

Q44896647-DEB004C9-87CE-4523-AAE7-421F7002A030

Q44896647-EFEA06E7-85F1-4346-A101-15082EF1402E

Q44896647-F0D5710C-912E-4AF2-B3B7-6937C39D535A

P2860

Q44896647-06218AAE-59EA-4246-924F-083E673B46C3

Q44896647-11657CB2-F9A1-4E8A-8BF8-1C146492C1B8

Q44896647-11D7A4E4-8310-4A43-B9EB-ED3AE18A5468

Q44896647-17E4A121-0A88-486D-A293-288E926F0D6A

Q44896647-2B9A271C-05A3-480D-8A8D-2644C7962F03

Q44896647-30E6116F-5878-4343-93BE-A6E849254CA2

Q44896647-37E6B6FB-F903-464C-B19C-35ED11E26ADD

Q44896647-3978F3EF-777D-431E-BDDE-3E28555C5D64

Q44896647-5EDAC5DF-0EC7-4DBE-AD70-9255E51DE520

Q44896647-60E47AA6-EFB4-4738-B0EF-46464B40BA9F

P2888

Q44896647-E5B5B9B2-59D4-4CBD-986D-73EA7EE061AF

P304

Q44896647-C67F723F-F8CD-4566-AC61-1AB000F22011

P31

Q44896647-6CF64FDA-525F-460A-B3C3-05BD16C601B9

P356

Q44896647-9049D255-BDE1-4A43-8BE6-99646D5B77A7

P407

Q44896647-6259C837-7EC0-4E73-98A6-C09B148982C9

P433

Q44896647-6B041B5E-6EE1-4F8F-A79E-9B6C24887816

P478

Q44896647-2BA45233-EA4E-44EF-BD87-098A568E5D73

P577

Q44896647-E710DC1C-6C6A-4C0E-9D2E-351F15B4B264

P5875

Q44896647-98E5EAC0-7AB3-4EDB-855F-508E20B7118A

P698

Q44896647-235829D9-05BA-4D73-9458-3D403B9DEE80

P356

S10549-013-2417-1

P1433

Breast Cancer Research and Treatment

P1476

Persistence in patients with b ...... trospective database analysis.

@en

P2093

G Haas

http://www.w3.org/2001/XMLSchema#string

J Kyvernitakis

http://www.w3.org/2001/XMLSchema#string

K Kostev

http://www.w3.org/2001/XMLSchema#string

M Bauer

http://www.w3.org/2001/XMLSchema#string

N Schmidt

http://www.w3.org/2001/XMLSchema#string

P Hadji

http://www.w3.org/2001/XMLSchema#string

V Ziller

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to therapy with oral antineoplastic agents

Adherence to Medication

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Estimates of cancer incidence and mortality in Europe in 2008.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

Adherence beliefs among breast cancer patients taking tamoxifen.

A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.

Methods for evaluation of medication adherence and persistence using automated databases.

Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome.

P2888

s10549-013-2417-1

P304

185-191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-013-2417-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234702589

http://www.w3.org/2001/XMLSchema#string

P698

23334803

http://www.w3.org/2001/XMLSchema#string